시장보고서
상품코드
1957423

메신저 리보핵산(mRNA) 합성 원료 시장 보고서(2026년)

Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Global Market Report 2026

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

메신저 리보핵산(mRNA) 합성 원료 시장 규모는 최근 꾸준히 확대하고 있습니다. 2025년 30억 3,000만 달러에서 2026년에는 31억 2,000만 달러로, CAGR 3.0%로 성장할 것으로 예상됩니다. 지난 수년간의 성장 요인으로는 백신 수요 증가, 분자생물학의 발전, 합성생물학 분야의 연구개발 투자 확대, 감염병 발생 증가, 효율적인 전사효소 개발 등을 꼽을 수 있습니다.

메신저 리보핵산(mRNA) 합성 원료 시장 규모는 향후 몇 년간 꾸준한 성장이 전망됩니다. 2030년에는 36억 5,000만 달러에 달하고, CAGR은 4.0%를 기록할 전망입니다. 예측 기간 동안 성장 요인으로는 mRNA 기반 치료법의 확대, 자동화된 mRNA 합성 플랫폼의 도입, 맞춤형 의료 이니셔티브의 증가, 생명공학 제조 기지의 성장, 뉴클레오티드 변형 기술의 혁신 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 합성 mRNA의 최적화, 고순도 원료 개발, 확장 가능한 체외 전사 공정 확립, mRNA 생산의 공급망 표준화, 품질 관리 및 규제 준수 등이 있습니다.

암 및 만성질환의 발생률 증가는 향후 몇 년 동안 mRNA 합성 원료 시장의 성장을 견인할 것으로 예상됩니다. 암은 비정상적인 세포가 통제할 수 없을 정도로 증식하여 주변 조직에 침윤하고 혈액이나 림프계를 통해 체내 다른 부위로 전이될 가능성이 있는 병입니다. 만성질환은 일반적으로 1년 이상 지속되는 상태, 지속적인 치료가 필요한 상태, 일상 활동을 제한하는 상태, 또는 이러한 요소의 조합을 동반하는 상태로 정의됩니다. mRNA 합성 원료는 암 및 만성질환 치료에 있어 면역원성 향상, 생산효율 향상, 생산기간 단축 등의 이점을 제공하기 때문에 신약개발, 백신 개발, RNA 기반 치료제 생산에 널리 활용되고 있습니다. 예를 들어, 미국암협회가 발표한 자료에 따르면, 2024년 1월 기준 미국에서는 2024년 200만 1,140건의 신규 암 발병과 61만 1,720명의 암 관련 사망이 예상되며, 이는 2023년 195만 8,310건의 발병과 60만 9,820명의 사망과 비교하여 증가하고 있습니다. 또한, 영국심장재단에 따르면 2025년 9월 기준 영국에서는 400만 명 이상의 남성과 360만 명 이상의 여성을 포함한 760만 명 이상이 심혈관질환을 앓고 있으며, 인구 고령화와 생존율 증가로 인해 2030년까지 약 100만 명, 2040년까지 약 200만 명의 환자 수 증가 증가할 것으로 예상됩니다. 따라서 암과 만성질환의 부담 증가가 mRNA 합성 원료의 수요를 견인하고 있습니다.

메신저 리보핵산(mRNA) 합성 원료 시장에서 사업을 전개하는 주요 기업들은 기술력 강화, 고품질 원료 포트폴리오 확대, 차세대 mRNA 치료제 생산 가속화를 위한 전략적 제휴를 중요시하고 있습니다. 전략적 제휴에는 생명공학 기업, 효소 개발 기업, 핵산 기술 제공업체 간의 공식적인 파트너십이 포함되며, mRNA의 수율, 순도, 순도, 안정성, 안전성을 향상시키는 첨단 체외 전사 효소, 변형된 뉴클레오티드, 캡핑 아날로그 및 기타 필수 인풋의 공동 개발이 포함됩니다. 공동 개발이 이루어지고 있습니다. 예를 들어, 2024년 9월 TriLink Biotechnologies는 Alphazyme LLC와 제휴하여 차세대 in vitro 전사 효소 'CleanScribe RNA Polymerase'를 발표하였습니다. 이 효소는 mRNA 합성 시 이중가닥 RNA 형성을 최대 85%까지 감소시켜 보다 안전하고 효과적인 mRNA 기반 치료제 개발에 도움을 줍니다.

자주 묻는 질문

  • 메신저 리보핵산(mRNA) 합성 원료 시장 규모는 어떻게 변화하고 있나요?
  • mRNA 합성 원료 시장의 성장 요인은 무엇인가요?
  • mRNA 합성 원료가 암 및 만성질환 치료에 어떤 이점을 제공하나요?
  • mRNA 합성 원료 시장에서 주요 기업들은 어떤 전략을 중요시하나요?
  • mRNA 합성 원료 시장의 주요 동향은 무엇인가요?

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의가 공급망에 미치는 영향, 코로나가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장에서 세계의 총 잠재 시장 규모(TAM)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자 환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

KSM

Messenger ribonucleic acid (mRNA) synthesis raw materials are ribonucleic components that support the accurate and efficient synthesis of mRNA molecules during in-vitro transcription processes, enabling the production of biologically functional synthetic RNAs. These materials are widely used in the manufacture of mRNA vaccines, which stimulate the body to generate an immune response against specific antigens, thereby enhancing overall immune capacity.

The main mRNA synthesis raw materials include capping agents, nucleotides, plasmid DNA, and others. Capping agents are amphiphilic molecules composed of a polar head group and a non-polar hydrocarbon tail, and they are used to introduce a modified cap structure onto an mRNA molecule during synthesis. This cap provides stability and protection to the mRNA, improving its translation efficiency and resistance to degradation. These raw materials are applied in areas such as therapeutic production, vaccine development, and other applications, and are used by biotechnology companies, pharmaceutical companies, research institutions, academic organizations, and others.

Tariffs have impacted the mRNA synthesis raw materials market by increasing the cost of importing essential nucleotides, enzymes, and plasmid DNA components, which are critical for vaccine and therapeutic production. The segments most affected include nucleotide and plasmid DNA suppliers, particularly in regions such as North America and Europe that rely heavily on imports from Asia. While tariffs have introduced supply chain challenges and cost pressures, they have also encouraged local manufacturing investments and diversification of sourcing strategies, which may strengthen domestic production capabilities over time.

The messenger ribonucleic acid (mrna) synthesis raw materials market research report is one of a series of new reports from The Business Research Company that provides messenger ribonucleic acid (mrna) synthesis raw materials market statistics, including messenger ribonucleic acid (mrna) synthesis raw materials industry global market size, regional shares, competitors with a messenger ribonucleic acid (mrna) synthesis raw materials market share, detailed messenger ribonucleic acid (mrna) synthesis raw materials market segments, market trends and opportunities, and any further data you may need to thrive in the messenger ribonucleic acid (mrna) synthesis raw materials industry. This messenger ribonucleic acid (mrna) synthesis raw materials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The messenger ribonucleic acid (mrna) synthesis raw materials market size has grown steadily in recent years. It will grow from $3.03 billion in 2025 to $3.12 billion in 2026 at a compound annual growth rate (CAGR) of 3.0%. The growth in the historic period can be attributed to growing demand for vaccines, advances in molecular biology, increasing r&d investments in synthetic biology, rise of infectious disease outbreaks, development of efficient transcription enzymes.

The messenger ribonucleic acid (mrna) synthesis raw materials market size is expected to see steady growth in the next few years. It will grow to $3.65 billion in 2030 at a compound annual growth rate (CAGR) of 4.0%. The growth in the forecast period can be attributed to expansion of mrna-based therapeutics, adoption of automated mrna synthesis platforms, increase in personalized medicine initiatives, growth of biotechnology manufacturing hubs, innovations in nucleotide modifications. Major trends in the forecast period include synthetic mrna optimization, high-purity raw material development, scalable in-vitro transcription processes, supply chain standardization for mrna production, quality control & regulatory compliance.

The rising incidence of cancer and chronic disorders is expected to drive the growth of the mRNA synthesis raw materials market in the coming years. Cancer is a condition in which abnormal cells grow uncontrollably, invade nearby tissues, and may spread to other parts of the body through the blood and lymphatic systems. Chronic disorders are broadly defined as conditions that last for a year or longer, require ongoing medical care, limit daily activities, or involve a combination of these factors. mRNA synthesis raw materials are widely used in drug discovery, vaccine development, and the production of RNA-based therapeutics, as they offer advantages such as enhanced immunogenicity, higher production efficiency, and shorter manufacturing timelines for the treatment of cancer and chronic diseases. For instance, in January 2024, according to data published by the American Cancer Society, the United States was projected to record 2,001,140 new cancer cases and 611,720 cancer-related deaths in 2024, compared with 1,958,310 cases and 609,820 deaths in 2023. In addition, in September 2025, according to the British Heart Foundation, more than 7.6 million people in the UK, including over 4 million men and more than 3.6 million women, were living with cardiovascular disease, with projections indicating an increase of around 1 million affected individuals by 2030 and approximately 2 million by 2040 due to population aging and improved survival rates. Therefore, the growing burden of cancer and chronic disorders is driving demand for mRNA synthesis raw materials.

Major companies operating in the messenger ribonucleic acid (mRNA) synthesis raw materials market are emphasizing strategic collaborations to strengthen technological capabilities, expand high-quality raw material portfolios, and accelerate the production of next-generation mRNA therapeutics. Strategic collaborations involve formal partnerships among biotechnology companies, enzyme developers, and nucleic acid technology providers to co-develop advanced in vitro transcription enzymes, modified nucleotides, capping analogs, and other essential inputs that enhance mRNA yield, purity, stability, and safety. For example, in September 2024, TriLink Biotechnologies partnered with Alphazyme LLC to launch CleanScribe RNA Polymerase, a next-generation in vitro transcription enzyme that reduces double-stranded RNA formation by up to 85% during mRNA synthesis, supporting the development of safer and more effective mRNA-based therapeutics.

In February 2025, Maravai LifeSciences acquired the DNA and RNA business of Officinae Bio for an undisclosed amount. Through this acquisition, Maravai LifeSciences aims to enhance its nucleic acid production capabilities and strengthen its support for innovative mRNA and DNA therapeutic development.

Major companies operating in the messenger ribonucleic acid (mrna) synthesis raw materials market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Lonza Group Ltd., Bio-Rad Laboratories Inc., Qiagen N.V., Maravai LifeSciences, Takara Bio Inc., GenScript Biotech Corporation, Promega Corporation, Integrated DNA Technologies Inc., LGC Biosearch Technologies, Merck KGaA, GeneCopoeia Inc., Bio-Synthesis Inc., BOC Sciences Inc., Bio Basic Inc., OriGene Technologies Inc., BioCat GmbH, Creative Biogene, Jena Bioscience GmbH, ATDBio Ltd.

North America was the largest region in the mRNA synthesis raw materials market in 2025. The regions covered in the messenger ribonucleic acid (mrna) synthesis raw materials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the messenger ribonucleic acid (mrna) synthesis raw materials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The mRNA synthesis raw materials market consists of sales of modified ribonucleoside triphosphates, polynucleotide tails, ribonucleoside diphosphate (NDPs), ribonucleoside monophosphate (NMPs), and ribonucleoside triphosphate (NTTs). Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses messenger ribonucleic acid (mrna) synthesis raw materials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for messenger ribonucleic acid (mrna) synthesis raw materials ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The messenger ribonucleic acid (mrna) synthesis raw materials market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Capping Agents; Nucleotides; Plasmid DNA; Other Types
  • 2) By Applications: Therapeutics Production; Vaccine Production; Other Applications
  • 3) By End-Users: Biotechnology Companies; Pharmaceutical Companies; Research And Academic Institutions; Other End-Users
  • Subsegments:
  • 1) By Capping Agents: 7-Methyl Guanylate (M7G) Capping Agents; Other Capping Agents
  • 2) By Nucleotides: Natural Nucleotides; Modified Nucleotides; Triphosphate Nucleotides
  • 3) By Plasmid DNA: Linearized Plasmid DNA; Circular Plasmid DNA; High-Purity Plasmid DNA
  • 4) By Other Types: Buffer Solutions; Enzymes; Other Auxiliary Materials
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Agilent Technologies Inc.; Lonza Group Ltd.; Bio-Rad Laboratories Inc.; Qiagen N.V.; Maravai LifeSciences; Takara Bio Inc.; GenScript Biotech Corporation; Promega Corporation; Integrated DNA Technologies Inc.; LGC Biosearch Technologies; Merck KGaA; GeneCopoeia Inc.; Bio-Synthesis Inc.; BOC Sciences Inc.; Bio Basic Inc.; OriGene Technologies Inc.; BioCat GmbH; Creative Biogene; Jena Bioscience GmbH; ATDBio Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Industry 4.0 & Intelligent Manufacturing
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Sustainability, Climate Tech & Circular Economy
    • 4.1.5 Artificial Intelligence & Autonomous Intelligence
  • 4.2. Major Trends
    • 4.2.1 Synthetic Mrna Optimization
    • 4.2.2 High-Purity Raw Material Development
    • 4.2.3 Scalable In-Vitro Transcription Processes
    • 4.2.4 Supply Chain Standardization For Mrna Production
    • 4.2.5 Quality Control & Regulatory Compliance

5. Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Analysis Of End Use Industries

  • 5.1 Biotechnology Companies
  • 5.2 Pharmaceutical Companies
  • 5.3 Research And Academic Institutions
  • 5.4 Contract Manufacturing Organizations (Cmos)
  • 5.5 Diagnostic Companies

6. Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Messenger ribonucleic acid (mRNA) Synthesis Raw Materials PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Segmentation

  • 9.1. Global Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Capping Agents, Nucleotides, Plasmid DNA, Other Types
  • 9.2. Global Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Therapeutics Production, Vaccine Production, Other Applications
  • 9.3. Global Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Biotechnology Companies, Pharmaceutical Companies, Research And Academic Institutions, Other End-Users
  • 9.4. Global Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Sub-Segmentation Of Capping Agents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 7-Methyl Guanylate (M7G) Capping Agents, Other Capping Agents
  • 9.5. Global Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Sub-Segmentation Of Nucleotides, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Natural Nucleotides, Modified Nucleotides, Triphosphate Nucleotides
  • 9.6. Global Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Sub-Segmentation Of Plasmid DNA, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Linearized Plasmid DNA, Circular Plasmid DNA, High-Purity Plasmid DNA
  • 9.7. Global Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Buffer Solutions, Enzymes, Other Auxiliary Materials

10. Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Regional And Country Analysis

  • 10.1. Global Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market

  • 11.1. Asia-Pacific Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Type, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market

  • 12.1. China Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Type, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market

  • 13.1. India Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Type, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market

  • 14.1. Japan Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Type, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market

  • 15.1. Australia Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Type, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market

  • 16.1. Indonesia Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Type, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market

  • 17.1. South Korea Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Type, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market

  • 18.1. Taiwan Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Type, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market

  • 19.1. South East Asia Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Type, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market

  • 20.1. Western Europe Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Type, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market

  • 21.1. UK Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Type, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market

  • 22.1. Germany Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Type, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market

  • 23.1. France Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Type, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market

  • 24.1. Italy Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Type, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market

  • 25.1. Spain Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Type, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market

  • 26.1. Eastern Europe Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Type, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market

  • 27.1. Russia Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Type, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market

  • 28.1. North America Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Type, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market

  • 29.1. USA Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Type, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market

  • 30.1. Canada Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Type, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market

  • 31.1. South America Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Type, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market

  • 32.1. Brazil Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Type, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market

  • 33.1. Middle East Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Type, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market

  • 34.1. Africa Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Type, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Regulatory and Investment Landscape

36. Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Competitive Landscape And Company Profiles

  • 36.1. Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Company Profiles
    • 36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Lonza Group Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Qiagen N.V. Overview, Products and Services, Strategy and Financial Analysis

37. Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Other Major And Innovative Companies

  • Maravai LifeSciences, Takara Bio Inc., GenScript Biotech Corporation, Promega Corporation, Integrated DNA Technologies Inc., LGC Biosearch Technologies, Merck KGaA, GeneCopoeia Inc., Bio-Synthesis Inc., BOC Sciences Inc., Bio Basic Inc., OriGene Technologies Inc., BioCat GmbH, Creative Biogene, Jena Bioscience GmbH

38. Global Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market

40. Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market High Potential Countries, Segments and Strategies

  • 40.1 Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제